Skip to content

Clinical trials

Diabetes Mellitus trials in China with no applicable phase

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Diabetes Mellitus Phase: Not applicable Country / region: China Clear all

114 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20072
20095
20101
20113
20125
20137
20144
20154
20167
20176
20185
20198
20203
20211
20229
202313
20249
202515
20265

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed49
Unknown status43
Recruiting14
Not yet recruiting3
Terminated3
Active, not recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Shanghai Jiao Tong University School of Medicine5
China National Center for Cardiovascular Diseases4
Chinese University of Hong Kong4
Huazhong University of Science and Technology4
Nanjing First Hospital, Nanjing Medical University4
Shanghai 6th People's Hospital4
Sun Yat-sen University4
First Affiliated Hospital Xi'an Jiaotong University3
Medtronic MiniMed, Inc.3
Andon Medical Co.,Ltd2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Diabetes Mellitus114
Diabetes Mellitus, Type 218
Hypertension12
Coronary Artery Disease7
Dyslipidemias5
Obesity5
Cardiovascular Diseases4
Diabetes Mellitus, Type 14
Hyperglycemia4
Insulin Resistance4

Trials

Showing 1 to 25 of 114. Each trial links to its page on Pharma Observatory.

14 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.